Cipla Share Price

• Overview
• News
• Analysis
• Recos
• Financials
• Forecast
• Technicals
• Peers
• Shareholdings
• MF
• F&O
• Corp Actions
• About
• More
  • MF
  • F&O
  • Corp Actions
  • About
• EnglishEnglishहिन्दीગુજરાતીमराठीবাংলাಕನ್ನಡதமிழ்తెలుగు
  Rank 90 - ET 5002022 ranking

Cipla News & Analysis

Cipla Share Recommendations

Peer Comparison

Cipla Shareholding Pattern

MF Ownership

• HDFC Flexi Cap Direct-G

  Equity: Flexi Cap

  4

  • 1,936.70

    Amount Invested (in Cr.)

  • 5.01%

    % of AUM

  • 2.67

    % Change (MoM basis)

• SBI Equity Hybrid Direct-G

  Hybrid: Aggressive Hybrid

  3

  • 1,383.36

    Amount Invested (in Cr.)

  • 2.31%

    % of AUM

  • 0.00

    % Change (MoM basis)

• HDFC Taxsaver Direct-G

  Equity: ELSS

  3

  • 565.92

    Amount Invested (in Cr.)

  • 5.01%

    % of AUM

  • 4.65

    % Change (MoM basis)

Cipla F&O Quote

Corporate Actions

About Cipla

Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 95,750.66 Crore) operating in Pharmaceuticals sector. Cipla Ltd. key Products/Revenue Segments include Pharmaceuticals, Royalty Income, Other Operating Revenue, Export Incentives and Scrap for the year ending 31-Mar-2022.For the quarter ended 30-06-2023, the company has reported a Consolidated Total Income of Rs 6,465.18 Crore, up 10.07 % from last quarter Total Income of Rs 5,873.93 Crore and up 18.01 % from last year same quarter Total Income of Rs 5,478.62 Crore. Company has reported net profit after tax of Rs 996.58 Crore in latest quarter.The company’s top management includes Dr.Y K Hamied, Ms.Samina Hamied, Mr.M K Hamied, Mr.Umang Vohra, Mr.S Radhakrishnan, Mr.Adil Zainulbhai, Mr.Ashok Sinha, Dr.Mandar Vaidya, Mr.P R Ramesh, Dr.Peter Mugyenyi, Ms.Punita Lal, Mr.Robert Stewart, Mr.Ashish Adukia, Mr.Rajendra Chopra. Company has Walker Chandiok & Co. LLP as its auditors. As on 30-06-2023, the company has a total of 80.72 Crore shares outstanding. Show More

Industry

Pharma - Indian

Key Indices Listed on

Nifty 50, Nifty 100, Nifty 200, + 33 more

Address

Cipla House,Peninsula Business Park,Ganpatrao Kadam Marg,Mumbai, Maharashtra - 400013

Contact

cosecretary@cipla.com

http://www.cipla.com

More Details

• Chairman's Speech
• Company History
• Directors Report
• Background information
• Company Management
• Listing Information
• Finished Products

Brands

Cipla

FAQs about Cipla share

• 1. What is Cipla share price and what are the returns for Cipla share?
  As on 29 Sep, 2023, 03:59 PM IST Cipla share price was up by 1.89% basis the previous closing price of Rs 1,164.05. Cipla share price was Rs 1,186.15. Return Performance of Cipla Shares:

  • 1 Week: Cipla share price moved up by 0.02%
  • 1 Month: Cipla share price moved down by 3.55%
  • 3 Month: Cipla share price moved up by 17.45%
  • 6 Month: Cipla share price moved up by 33.62%
• 2. Is Cipla a good buy?
  As per Refinitiv (erstwhile Thomson Reuters), overall mean recommendation by 35 analysts for Cipla stock is to Buy. Recommendation breakup is as follows

  • 11 analysts are recommending Strong Buy
  • 13 analysts are recommending to Buy
  • 8 analysts are recommending to Hold
  • 2 analysts are recommending to Sell
  • 1 analyst is recommending Strong Sell
• 3. Who's the owner of Cipla?
  Promoter,DII and FII owns 33.55, 21.72 and 27.42 shares of Cipla as on 30 Jun 2023

  • Promoter holding have gone down from 33.55 (31 Mar 2023) to 33.47 (30 Jun 2023)
  • Domestic Institutional Investors holding has gone up from 21.72 (31 Mar 2023) to 23.83 (30 Jun 2023)
  • Foreign Institutional Investors holding have gone down from 27.42 (31 Mar 2023) to 25.49 (30 Jun 2023)
  • Other investor holding have gone down from 17.31 (31 Mar 2023) to 17.21 (30 Jun 2023)
• 4. What is the market cap of Cipla?
  Market Capitalization of Cipla stock is Rs 95,750.66 Cr.
• 5. What has been highest price of Cipla share in last 52 weeks?
  52 Week high of Cipla share is Rs 1,277.90 while 52 week low is Rs 852.00
• 6. Which are the key peers to Cipla?
  Within Pharmaceuticals sector Cipla, Divi's Laboratories Ltd., Dr. Reddy's Laboratories Ltd., Mankind Pharma Ltd., Torrent Pharmaceuticals Ltd., Zydus Lifesciences Ltd., Lupin Ltd., Aurobindo Pharma Ltd., Alkem Laboratories Ltd., Biocon Ltd. and Syngene International Ltd. are usually compared together by investors for analysis.
• 7. How can I quickly analyze Cipla stock?
  Key Metrics for Cipla are:

  • PE Ratio of Cipla is 30.82
  • Earning per share of Cipla is 38.49
  • Price/Sales ratio of Cipla is 3.19
  • Price to Book ratio of Cipla is 4.21